Scholarly Works - Preprints
Preprint
·
November 18, 2020
BACKGROUNDThere is much public debate regarding the high cost of insulin. With 1-in-4 patients in the United States with type 1 diabetes reporting difficulties affording insulin, there is ...
Full text
Cite